SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-24-001681
Filing Date
2024-05-10
Accepted
2024-05-10 16:10:36
Documents
16
Period of Report
2024-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2431441.htm   iXBRL 8-K 32736
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 79519
7 image00002.jpg GRAPHIC 14847
  Complete submission text file 0001178913-24-001681.txt   323491

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA entx-20240510.xsd EX-101.SCH 4676
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20240510_def.xml EX-101.DEF 17919
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20240510_lab.xml EX-101.LAB 27305
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20240510_pre.xml EX-101.PRE 20104
20 EXTRACTED XBRL INSTANCE DOCUMENT zk2431441_htm.xml XML 6720
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 24934947
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)